Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...
Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA ®, the first and only daytime intraoral neuromuscular stimulation device for ...
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue. The Food and Drug Administration (FDA) has ...
BOSTON & LONDON — Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for ...
BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that Waha ...
Signifier Medical Technologies Limited (“Signifier”), a global leader in medical technology for sleep-disordered breathing, announces that it has achieved the EU MDR certification for eXciteOSA®, its ...
The proceeds of the financing will be directed towards commercialization of eXcite OSA in Signifier’s core target markets, continued development of Signifier’s proprietary digital patient and ...
Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback